Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis

BACKGROUND: Ezetimibe-statin combination therapy has been found to reduce low density lipoprotein cholesterol levels and the risk of major adverse cardiovascular events (MACEs) in large trials. We sought to examine the differential effect of ezetimibe on MACEs when added to statins according to the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrinol Metab (Seoul)
Hauptverfasser: Hong, Namki, Lee, Yong-ho, Tsujita, Kenichi, Gonzalez, Jorge A., Kramer, Christopher M., Kovarnik, Tomas, Kouvelos, George N., Suzuki, Hiromichi, Han, Kyungdo, Lee, Chan Joo, Park, Sung Ha, Lee, Byung-Wan, Cha, Bong-Soo, Kang, Eun Seok
Format: Artigo
Sprache:Inglês
Veröffentlicht: Korean Endocrine Society 2018
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6021322/
https://ncbi.nlm.nih.gov/pubmed/29766679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2018.33.2.219
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge